Hostname: page-component-745bb68f8f-lrblm Total loading time: 0 Render date: 2025-01-07T18:43:46.873Z Has data issue: false hasContentIssue false
  • English
  • Français

Homocysteine is associated with hippocampal and white matter atrophy in older subjects with mild hypertension

Published online by Cambridge University Press:  07 April 2010

Michael J. Firbank ,
Sunil K. Narayan ,
Brian K Saxby ,
Gary A. Ford  and
John T. O'Brien
Michael J. Firbank*
Affiliation:
Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, U.K.
Sunil K. Narayan
Affiliation:
Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, U.K.
Brian K Saxby
Affiliation:
Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, U.K.
Gary A. Ford
Affiliation:
Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, U.K.
John T. O'Brien
Affiliation:
Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, U.K.
*
Correspondence should be addressed to: Michael Firbank, Wolfson Research Centre, Institute for Ageing and Health, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne, NE4 5PL, U.K. Phone: +44 (0) 191 248 1319; Fax: +44 (0) 191 248 1301. Email: [email protected].
Get access

Abstract

Background: Plasma homocysteine has been associated with reduced brain volumes in cross-sectional studies. We aimed to investigate if homocysteine is associated with ongoing atrophy, and if so, if this is localized to gray or white matter.

Methods: In a group of 80 hypertensive subjects aged 70–90 years (from the SCOPE study) MRI images were obtained at two time points two years apart. Rates of gray and white matter and hippocampal atrophy were determined by calculating the difference in segmentation probability maps using SPM5. Plasma homocysteine, folate, B12 and creatinine were measured at study end.

Results: Homocysteine levels correlated with white matter atrophy rate (p = 0.006) hippocampal baseline volume (p = 0.011) and hippocampal atrophy rate (p = 0.004) but not global gray matter atrophy or baseline gray or white matter volumes. The correlations remained significant (p < 0.05) after controlling for subject age, blood pressure, folate levels and white matter lesion volume.

Conclusion: In older hypertensives, plasma homocysteine levels are associated with increased rates of progressive white matter and hippocampal atrophy.

Keywords

brain atrophyMRIhomocysteinehippocampusdementia
Type
Research Article
Information
International Psychogeriatrics , Volume 22 , Issue 5 , August 2010 , pp. 804 - 811
Copyright
Copyright © International Psychogeriatric Association 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Back, T., Hemmen, T. and Schüler, O. G. (2004). Lesion evolution in cerebral ischemia. Journal of Neurology, 251, 388–397.CrossRefGoogle ScholarPubMed
Clarke, R., Smith, A. D., Jobst, K. A., Refsum, H., Sutton, L. and Ueland, P. M. (1998). Folate, Vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Archives of Neurology, 55, 1449–1455.CrossRefGoogle ScholarPubMed
den Heijer, T. et al. (2003). Homocysteine and brain atrophy on MRI of non-demented elderly. Brain, 126, 170–175.Google Scholar
Fazekas, F. et al. (1993). Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology, 43, 1683–1689.CrossRefGoogle ScholarPubMed
Firbank, M. J., Wiseman, R. M., Burton, E. J., Saxby, B. K., O'Brien, J. T. and Ford, G. A. (2007). Brain atrophy and white matter hyperintensity change in older adults and relationship to blood pressure. Journal of Neurology, 254, 713–721.CrossRefGoogle ScholarPubMed
Firbank, M. J., Barber, R., Burton, E. J. and O'Brien, J. T. (2008). Validation of a fully automated hippocampal segmentation method on patients with dementia. Human Brain Mapping, 29, 1442–1449.CrossRefGoogle ScholarPubMed
Hansson, L. et al. (1999). Study on Cognition and Prognosis in the Elderly (SCOPE). Blood Pressure, 8, 177–183.CrossRefGoogle Scholar
Hogervorst, E., Huppert, F., Matthews, F. E. and Brayne, C. (2008). Thyroid function and cognitive decline in the MRC Cognitive Function and Ageing Study. Psychoneuroendocrinology, 33, 1013–1022.Google Scholar
Lonati, S. et al. (2004). Analytical performance and method comparison study of the total homocysteine fluorescence polarization immunoassay (FPIA) on the AxSYM analyzer. Clinical Chemistry and Laboratory Medicine, 42, 228–234.Google Scholar
Longstreth, W. T. et al. (2004). Plasma total homocysteine levels and cranial magnetic resonance imaging findings in elderly persons: the Cardiovascular Health Study. Archives of Neurology, 61, 67–72.CrossRefGoogle ScholarPubMed
Narayan, S. K. et al. (submitted). Plasma homocysteine levels are associated with increased brain atrophy rates in older subjects with mild hypertension. Stroke.Google Scholar
Obeid, R. and Herrmann, W. (2006). Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Letters, 580, 2994–3005.Google Scholar
Ozmen, B., Ozmen, D., Parildar, Z., Mutaf, I., Turgan, N. and Bayindir, O. (2006). Impact of renal function or folate status on altered plasma homocysteine levels in hypothyroidism. Endocrine Journal, 53, 119–124.Google Scholar
Peper, J. S., Brouwer, R. M., Boomsma, D. I., Kahn, R. S. and Hulshoff Pol, H. E. (2007). Genetic influences on human brain structure: A review of brain imaging studies in twins. Human Brain Mapping, 28, 464–473.CrossRefGoogle ScholarPubMed
Pernet, P., Lasnier, E. and Vaubourdolle, M. (2000). Evaluation of the AxSYM homocysteine assay and comparison with the IMx homocysteine assay. Clinical Chemistry, 46, 1440–1441.CrossRefGoogle ScholarPubMed
Popp, J. et al. (2009). Homocysteine metabolism and cerebrospinal fluid markers for Alzheimer's disease. Journal of Alzheimer's Disease, 18, 819–828.CrossRefGoogle ScholarPubMed
Rasmussen, K. and Møllerer, J. (2001). Methodologies of testing. In Carmel, R. and Jacobsen, D. W. (eds.), Homocysteine in Health and Disease. Cambridge: Cambridge University Press.Google Scholar
Ravaglia, G. et al. (2007). Blood inflammatory markers and risk of dementia: The conselice study of brain aging. Neurobiology of Aging, 28, 1810–1820.CrossRefGoogle ScholarPubMed
Sachdev, P. S. (2005). Homocysteine and brain atrophy. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 29, 1152–1161.Google Scholar
Sachdev, P. et al. (2004). Homocysteine and the brain in midadult life – Evidence for an increased risk of leukoaraiosis in men. Archives of Neurology, 61, 1369–1376.CrossRefGoogle ScholarPubMed
Saxby, B. K., Harrington, F., Wesnes, K., McKeith, I. G. and Ford, G. A. (2008). Candesartan and cognitive decline in older patients with hypertension: a substudy of the SCOPE trial. Neurology, 70, 1858–1866.Google Scholar
Seshadri, S. et al. (2002). Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. New England Journal of Medicine, 346, 476–483.CrossRefGoogle ScholarPubMed
Seshadri, S. et al. (2008). Association of plasma total homocysteine levels with subclinical brain injury. Archives of Neurology, 65, 642–649.Google Scholar
Shuter, B., Yeh, I. B., Graham, S., Au, C. and Wang, S.-C. (2008). Reproducibility of brain tissue volumes in longitudinal studies: effects of changes in signal-to-noise ratio and scanner software. Neuroimage, 41, 371–379Google Scholar
Vermeer, S. E. et al. (2002). Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam scan study. Annals of Neurology, 51, 285–289.CrossRefGoogle ScholarPubMed
Whalley, L. J. et al. (2003). Plasma vitamin C, cholesterol and homocysteine are associated with grey matter volume determined by MRI in non-demented old people. Neuroscience Letters, 341, 173–176.CrossRefGoogle ScholarPubMed
Williams, J. H., Pereira, E. A. C., Budge, M. M. and Bradley, K. M. (2002). Minimal hippocampal width relates to plasma homocysteine in community-dwelling older people. Age and Ageing, 31, 440–444.Google Scholar